Jason Wittes
Stock Analyst at Roth MKM
(3.42)
# 954
Out of 4,711 analysts
55
Total ratings
51.06%
Success rate
4.34%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $82.63 | +39.17% | 4 | Dec 17, 2024 | |
| MGRM Monogram Technologies | Initiates: Buy | $4 | $2.58 | +55.04% | 1 | Dec 9, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Buy | $11 | $4.05 | +171.60% | 1 | Nov 11, 2024 | |
| OFIX Orthofix Medical | Reiterates: Buy | $20 → $22 | $17.43 | +26.22% | 4 | Nov 8, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $2 | $0.35 | +474.71% | 1 | Sep 6, 2024 | |
| IRMD IRADIMED CORPORATION | Maintains: Buy | $65 → $60 | $54.65 | +9.79% | 2 | Aug 2, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $7.16 | +402.79% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $4.68 | +135.04% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.28 | +681.25% | 1 | Jun 26, 2024 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $100 | $92.12 | +8.55% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.72 | +481.40% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $364.60 | +11.08% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.31 | +116.45% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.85 | +386.49% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $43.12 | +73.93% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $9.35 | +135.29% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $107.12 | +12.02% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $169.52 | +21.52% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $187.59 | -22.70% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $9.24 | +62.34% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $30.80 | +549.35% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $32.20 | -19.25% | 1 | Feb 22, 2017 |
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $82.63
Upside: +39.17%
Monogram Technologies
Dec 9, 2024
Initiates: Buy
Price Target: $4
Current: $2.58
Upside: +55.04%
TriSalus Life Sciences
Nov 11, 2024
Initiates: Buy
Price Target: $11
Current: $4.05
Upside: +171.60%
Orthofix Medical
Nov 8, 2024
Reiterates: Buy
Price Target: $20 → $22
Current: $17.43
Upside: +26.22%
Allurion Technologies
Sep 6, 2024
Initiates: Buy
Price Target: $2
Current: $0.35
Upside: +474.71%
IRADIMED CORPORATION
Aug 2, 2024
Maintains: Buy
Price Target: $65 → $60
Current: $54.65
Upside: +9.79%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.16
Upside: +402.79%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $4.68
Upside: +135.04%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $92.12
Upside: +8.55%
May 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.72
Upside: +481.40%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $364.60
Upside: +11.08%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.31
Upside: +116.45%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.85
Upside: +386.49%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $43.12
Upside: +73.93%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $9.35
Upside: +135.29%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $107.12
Upside: +12.02%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $169.52
Upside: +21.52%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $187.59
Upside: -22.70%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $9.24
Upside: +62.34%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $30.80
Upside: +549.35%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $32.20
Upside: -19.25%